Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment.

Myeloma cells disturb a normally balanced bone remodeling process. This imbalance of bone metabolism may cause osteopenic bones, focal osteolytic lesions and clinical symptoms. The excess bone resorption resulting in osteolytic lesions has traditionally been perceived as irreversible. We